-

Cresco Labs Announces May Conference Participation

CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced planned participation in upcoming conferences in May 2024.

19th Annual Needham Technology, Media & Consumer Conference, May 16, 2024, Virtual: Management will participate in a fireside chat and one-on-one meetings.

8th Annual Canaccord Global Cannabis Conference, May 23, 2024, New York City: Management will participate in panel and one-on-one meetings.

About Cresco Labs Inc.

Cresco Labs’ mission is to normalize and professionalize the cannabis industry through a CPG approach to building national brands and a customer-focused retail experience, while acting as a steward for the industry on legislative and regulatory-focused initiatives. As a leader in cultivation, production and branded product distribution, the Company is leveraging its scale and agility to grow its portfolio of brands that include Cresco, High Supply, FloraCal, Good News, Wonder Wellness Co., Mindy’s and Remedi, on a national level. The Company also operates highly productive dispensaries nationally under the Sunnyside brand that focus on building patient and consumer trust and delivering ongoing education and convenience in a wonderfully traditional retail experience. Through year-round policy, community outreach and SEED initiative efforts, Cresco Labs embraces the responsibility to support communities through authentic engagement, economic opportunity, investment, workforce development and legislative initiatives designed to create the most responsible, respectable and robust cannabis industry possible. Learn more about Cresco Labs’ journey by visiting www.crescolabs.com or following the Company on Facebook, X or LinkedIn.

Contacts

Media
Jason Erkes, Chief Communications Officer
press@crescolabs.com
312-953-2767

Investors
investors@crescolabs.com

General Inquiries
312-929-0993
info@crescolabs.com

Cresco Labs

CNSX:CL

Release Summary
Cresco Labs Announces May Conference Participation
Release Versions

Contacts

Media
Jason Erkes, Chief Communications Officer
press@crescolabs.com
312-953-2767

Investors
investors@crescolabs.com

General Inquiries
312-929-0993
info@crescolabs.com

More News From Cresco Labs

Cresco Labs’ Disciplined Strategy Drives Record Cash Flow in 2024 Financial Results

CHICAGO--(BUSINESS WIRE)--Cresco Labs’ Disciplined Strategy Drives Record Cash Flow in 2024 Financial Results...

Cresco Labs to Operate Kentucky’s Largest Medical Cannabis Cultivation License

CHICAGO--(BUSINESS WIRE)--Cresco Labs to Operate Kentucky’s Largest Medical Cannabis Cultivation License...

Cresco Labs to Report Fourth Quarter 2024 Financial Results on March 12, 2025

CHICAGO--(BUSINESS WIRE)--CRESCO LABS TO REPORT FOURTH QUARTER 2024 FINANCIAL RESULTS ON MARCH 12, 2025...
Back to Newsroom
  1. There was an issue with the authorization server. Please contact support if the issue persists.